MabPlex International
Fremont
About MabPlex International
MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. They offer partners contract services from DNA to finished drug product. They offer comprehensive biologics development and manufacturing solutions for customers globally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $129.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2020)
- Website: mabplex.com
Industries & Categories
Biotechnology, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/mabplex-international-11604 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.